Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.dsx.2020.08.014 http://scihub22266oqcxt.onion/10.1016/j.dsx.2020.08.014 32862098!7439970!32862098     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32862098&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Diabetes+Metab+Syndr 2020 ; 14 (6): 1595-1602 Nephropedia Template TP {{tp|p=32862098|t=2020. Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence |pdf=|usr=}}{{32862098}} gab.com Text Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence JO: Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=32862098 #FOAvip BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) spreads rapidly and within no time, it has been declared a pandemic by the World Health Organization. Evidence suggests diabetes to be a risk factor for the progression and poor prognosis of COVID-19. Therefore, we aimed to understand the pooled prevalence of diabetes in patients infected with COVID-19. We also aimed to compute the risk of mortality and ICU admissions in COVID-19 patients with and without diabetes. METHODS: A comprehensive literature search was performed in PubMed to identify the articles reporting the diabetes prevalence and risk of mortality or ICU admission in COVID-19 patients. The primary outcome was to compute the pooled prevalence of diabetes in COVID-19 patients. Secondary outcomes included risk of mortality and ICU admissions in COVID-19 patients with diabetes compared to patients without diabetes. RESULTS: This meta-analysis was based on a total of 23007 patients from 43 studies. The pooled prevalence of diabetes in patients infected with COVID-19 was found to be 15% (95% CI: 12%-18%), p = <0.0001. Mortality risk was found to be significantly higher in COVID-19 patients with diabetes as compared to COVID-19 patients without diabetes with a pooled risk ratio of 1.61 (95% CI: 1.16-2.25%), p = 0.005. Likewise, risk of ICU admission rate was significantly higher in COVID-19 patients with diabetes as compared to COVID-19 patients without diabetes with a pooled risk ratio of 1.88 (1.20%-2.93%), p = 0.006. CONCLUSION: This meta-analysis found a high prevalence of diabetes and higher mortality and ICU admission risk in COVID-19 patients with diabetes. Twit Text FOAVip Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence ????Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=32862098 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32862098 #FOAvip English Wikipedia <ref>{{Cite pmid|32862098}}</ref> Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence #MMPMID32862098 Hussain S; Baxi H; Chand Jamali M; Nisar N; Hussain MS Diabetes Metab Syndr 2020[Nov]; 14 (6): 1595-1602 PMID32862098show ga BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) spreads rapidly and within no time, it has been declared a pandemic by the World Health Organization. Evidence suggests diabetes to be a risk factor for the progression and poor prognosis of COVID-19. Therefore, we aimed to understand the pooled prevalence of diabetes in patients infected with COVID-19. We also aimed to compute the risk of mortality and ICU admissions in COVID-19 patients with and without diabetes. METHODS: A comprehensive literature search was performed in PubMed to identify the articles reporting the diabetes prevalence and risk of mortality or ICU admission in COVID-19 patients. The primary outcome was to compute the pooled prevalence of diabetes in COVID-19 patients. Secondary outcomes included risk of mortality and ICU admissions in COVID-19 patients with diabetes compared to patients without diabetes. RESULTS: This meta-analysis was based on a total of 23007 patients from 43 studies. The pooled prevalence of diabetes in patients infected with COVID-19 was found to be 15% (95% CI: 12%-18%), p = <0.0001. Mortality risk was found to be significantly higher in COVID-19 patients with diabetes as compared to COVID-19 patients without diabetes with a pooled risk ratio of 1.61 (95% CI: 1.16-2.25%), p = 0.005. Likewise, risk of ICU admission rate was significantly higher in COVID-19 patients with diabetes as compared to COVID-19 patients without diabetes with a pooled risk ratio of 1.88 (1.20%-2.93%), p = 0.006. CONCLUSION: This meta-analysis found a high prevalence of diabetes and higher mortality and ICU admission risk in COVID-19 patients with diabetes. |*Cost of Illness[MESH] |*Pragmatic Clinical Trials as Topic/methods[MESH] |COVID-19/diagnosis/*mortality[MESH] |Diabetes Mellitus/diagnosis/*mortality[MESH] |Hospitalization/trends[MESH] |Humans[MESH] |Intensive Care Units/trends[MESH]Burden of diabetes mellitus and its impact on COVID-19 patients: A met(epmc).pdf DeepDyve Pubget Overpricing